CBS 2019
CBSMD教育中心
中 文

Pulmonary Hypertension

Abstract

Recommended Article

Pulmonary Artery Denervation for Patients With Residual Pulmonary Hypertension After Pulmonary Endarterectomy Pulmonary Artery Denervation Attenuates Pulmonary Arterial Remodeling in Dogs With Pulmonary Arterial Hypertension Induced by Dehydrogenized Monocrotaline Factors associated with pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc) Management of pulmonary hypertension from left heart disease in candidates for orthotopic heart transplantation Skeletal muscle mitochondrial oxidative phosphorylation function in idiopathic pulmonary arterial hypertension: in vivo and in vitro study Sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: A Phase IIb, randomised, double-blind, placebo-controlled study - Rationale and study design Pulmonary Arterial Hypertension With Abnormal V/Q Single-Photon Emission Computed Tomography Immunotherapy of Endothelin-1 Receptor Type A for Pulmonary Arterial Hypertension

Review ArticleVolume 75, Issue 19, May 2020

JOURNAL:JACC Article Link

Challenges and Special Aspects of Pulmonary Hypertension in Middle- to Low-Income Regions: JACC State-of-the-Art Review

B Hasan, and on behalf of the European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, CSC, PASCAR, PCS, and PCSI. Keywords: consensus statement; middle- and low-income countries; pulmonary hypertension

Full Text PDF